Rock Creek takes in $760,024 from private placement of common stock

5,066,825 shares sold at $0.15 each with warrants for 4,208,413 shares

By Devika Patel

Knoxville, Tenn., Jan. 30 – Rock Creek Pharmaceuticals, Inc. completed a $760,024 private placement of stock on Jan. 28, according to an 8-K filed Friday with the Securities and Exchange Commission.

The company sold 5,066,825 common shares at $0.15 apiece. The price per share is a 16.67% discount to the Jan. 27 closing share price of $0.18.

The investors also received warrants for 4,208,413 shares, which are exercisable until Jan. 27, 2022 at $0.15, which is also a 16.67% discount to the Jan. 27 closing share price.

The pharmaceutical company is based in Sarasota, Fla.

Issuer:	Rock Creek Pharmaceuticals, Inc.
Issue:	Common stock
Amount:	$760,024
Shares:	5,066,825
Price:	$0.15
Warrants:	For 4,208,413 shares
Warrant expiration:	Jan. 27, 2022
Warrant strike price:	$0.15
Settlement date:	Jan. 28
Stock symbol:	Nasdaq: RCPI
Stock price:	$0.18 at close Jan. 27
Market capitalization:	$34.95 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.